PHARMANIAGA BHDPHARMANIAGA BHDPHARMANIAGA BHD

PHARMANIAGA BHD

No trades
See on Supercharts

PHARMA fundamentals

PHARMANIAGA BHD financial statements, including revenue, expenses, profit, and loss

The total revenue of PHARMA for the last quarter is 789.81 M MYR, and it's 10.81% lower compared to the previous quarter. The net income of Q4 23 is -32.72 M MYR.

Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: MYR
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth